Use Of Heterodimeric IL-15 In Adoptive Cell Transfer Read more about Use Of Heterodimeric IL-15 In Adoptive Cell Transfer US Application 62/497,948Filed on 2016-12-08
Method of Treating Obesity, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Including Non-Alcoholic Steatohepatitis Read more about Method of Treating Obesity, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Including Non-Alcoholic Steatohepatitis US Application 62/465,009Filed on 2017-02-28
CHIMERIC ANTIGEN RECEPTORS AND THEIR USES Read more about CHIMERIC ANTIGEN RECEPTORS AND THEIR USES US Application 62/506,268Filed on 2017-05-15
Phenyl Indole Allosteric Inhibitors Of P97 ATPase Read more about Phenyl Indole Allosteric Inhibitors Of P97 ATPase US Application 62/244,497Filed on 2015-10-21
Human Monoclonal Antibodies Against FLT3 and Uses Thereof Read more about Human Monoclonal Antibodies Against FLT3 and Uses Thereof US Application 62/437,547Filed on 2016-12-21
ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS Read more about ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS US Application 62/425,231Filed on 2016-11-22
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US Application 62/418,461Filed on 2016-11-07
Synergistic Anti-Tumor Effect of HMG Protein in Combination with Anti-CD4 Antibody or Immune Checkpoint Regulator Read more about Synergistic Anti-Tumor Effect of HMG Protein in Combination with Anti-CD4 Antibody or Immune Checkpoint Regulator US Application 62/385,588Filed on 2016-09-09
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target US Application 62/253,000Filed on 2015-11-09
IL-6 And IL-17A As Classifiers Of Lung Cancer Mortality For Stage I Adenocarcinoma Read more about IL-6 And IL-17A As Classifiers Of Lung Cancer Mortality For Stage I Adenocarcinoma US Application 62/412,690Filed on 2016-10-25